At Manningham Medical Centre, you can find all the data about Prax Medical Studies. We have collected data about general practitioners, medical and surgical specialists, dental, pharmacy and more. Please see the links below for the information you need.


A Clinical Trial of Adjunctive and Monotherapy PRAX-114 …

    https://clinicaltrials.gov/ct2/show/NCT04969510
    A sub-study to investigate the pharmacokinetics (PK) of PRAX-114 and metabolites when dosed in the evening in participants with MDD will be conducted in a …

A Clinical Trial of PRAX-944 in Participants With …

    https://clinicaltrials.gov/ct2/show/NCT05021978
    This is a 2-part clinical trial to evaluate the efficacy, safety, and tolerability of 40 and 120 mg oral PRAX-944 compared to placebo in the treatment of adults with …

Praxis Precision Medicines Reports PRAX-114 …

    https://www.globenewswire.com/news-release/2021/08/16/2281029/0/en/Praxis-Precision-Medicines-Reports-PRAX-114-Perimenopausal-Depression-PMD-Phase-2a-Proof-of-Concept-Trial-Results-and-Announces-Plans-to-Advance-to-Phase-2b-Study-in-Women-with-Men.html
    PRAX-114 is an extrasynaptic GABA A receptor preferring positive allosteric modulator (PAM) under development for the potential treatment of patients suffering from …

A Clinical Trial of PRAX-114 in Participants With Major …

    https://clinicaltrials.gov/ct2/show/NCT04832425
    This is a randomized, double-blind, placebo-controlled clinical trial to assess the efficacy and safety of PRAX-114 in participants with moderate to severe major …

Praxis Precision Medicines Reports Positive Topline Results from …

    https://investors.praxismedicines.com/news-releases/news-release-details/praxis-precision-medicines-reports-positive-topline-results-prax
    PRAX-944 is currently in clinical development for the treatment of essential tremor (ET) in the Essential1 study, a randomized, double-blind, placebo-controlled …

Praxis Precision Medicines Reports Positive Topline …

    https://www.globenewswire.com/news-release/2022/05/09/2439017/0/en/Praxis-Precision-Medicines-Reports-Positive-Topline-Results-from-PRAX-944-Phase-2a-Study-in-Essential-Tremor-Patients.html
    PRAX-944 is currently in clinical development for the treatment of essential tremor (ET) in the Essential1 study, a randomized, double-blind, placebo-controlled …

A Clinical Trial of PRAX-114 in Participants With Post …

    https://www.clinicaltrials.gov/ct2/show/NCT05260541
    This trial will evaluate the efficacy and safety of oral PRAX-114 flexibly dosed at 40 to 60 mg for 4 weeks compared to placebo in adults with PTSD. The OLE period …

A Clinical Trial of PRAX-114 in Participants With …

    https://clinicaltrials.gov/ct2/show/NCT05387642
    Has a history or clinical evidence of other medical, neurological, or psychiatric condition that may explain or cause tremor, including but not limited to …

Praxis Precision Medicines, Inc. (PRAX) - Yahoo!

    https://finance.yahoo.com/quote/PRAX/
    Praxis Precision Medicines, Inc. (PRAX) Stock Price, News, Quote & History - Yahoo Finance U.S. Markets close in 4 hrs 38 mins Praxis Precision Medicines, Inc. (PRAX) …

PRAX-222-111 EMBRAVE Study Pre-screen

    https://embravestudy.com/index.asp
    PRAX-222 is an investigational antisense oligonucleotide (ASO) with the potential to be the first disease-modifying treatment for early-onset SCN2A Developmental and Epileptic …



Need more information about Prax Medical Studies?

At Manningham Medical Centre, we collected data on more than just Prax Medical Studies. There is a lot of other useful information. Visit the related pages or our most popular pages. Also check out our Doctors page.